Boston Scientific Current Ratio 2006-2020 | BSX

Current and historical current ratio for Boston Scientific (BSX) from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Boston Scientific current ratio for the three months ending March 31, 2020 was 1.21.
Boston Scientific Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $4.82B $3.98B 1.21
2019-12-31 $4.70B $4.87B 0.97
2019-09-30 $4.85B $4.25B 1.14
2019-06-30 $6.33B $4.85B 1.31
2019-03-31 $6.23B $4.48B 1.39
2018-12-31 $4.00B $5.26B 0.76
2018-09-30 $3.97B $5.08B 0.78
2018-06-30 $3.93B $4.75B 0.83
2018-03-31 $4.08B $4.99B 0.82
2017-12-31 $3.82B $5.65B 0.68
2017-09-30 $3.48B $4.83B 0.72
2017-06-30 $3.22B $4.30B 0.75
2017-03-31 $3.03B $3.49B 0.87
2016-12-31 $3.24B $3.59B 0.90
2016-09-30 $3.18B $3.02B 1.06
2016-06-30 $3.33B $3.18B 1.05
2016-03-31 $3.16B $2.61B 1.21
2015-12-31 $3.47B $2.43B 1.43
2015-09-30 $3.46B $2.24B 1.55
2015-06-30 $3.77B $1.94B 1.95
2015-03-31 $3.19B $2.46B 1.30
2014-12-31 $3.61B $2.85B 1.27
2014-09-30 $3.18B $1.82B 1.75
2014-06-30 $3.21B $1.77B 1.81
2014-03-31 $2.94B $1.72B 1.71
2013-12-31 $3.01B $1.82B 1.65
2013-09-30 $3.53B $1.90B 1.85
2013-06-30 $3.50B $2.48B 1.41
2013-03-31 $3.10B $1.64B 1.90
2012-12-31 $3.02B $1.77B 1.71
2012-09-30 $3.17B $1.82B 1.75
2012-06-30 $3.11B $1.79B 1.73
2012-03-31 $3.09B $1.67B 1.85
2011-12-31 $3.11B $1.81B 1.72
2011-09-30 $3.21B $1.89B 1.70
2011-06-30 $3.15B $1.89B 1.66
2011-03-31 $3.57B $2.04B 1.75
2010-12-31 $3.62B $2.61B 1.39
2010-09-30 $3.56B $2.96B 1.20
2010-06-30 $3.99B $3.72B 1.07
2010-03-31 $3.75B $2.91B 1.29
2009-12-31 $4.60B $3.02B 1.52
2009-09-30 $4.96B $3.18B 1.56
2009-06-30 $4.80B $2.75B 1.74
2009-03-31 $4.57B $2.43B 1.88
2008-12-31 $5.45B $3.23B 1.69
2008-09-30 $5.29B $3.54B 1.49
2008-06-30 $5.17B $3.04B 1.70
2008-03-31 $5.24B $3.39B 1.55
2007-12-31 $5.94B $3.25B 1.83
2007-09-30 $4.69B $3.38B 1.39
2007-06-30 $4.94B $2.97B 1.66
2007-03-31 $4.58B $2.37B 1.93
2006-12-31 $6.03B $2.63B 2.29
2006-09-30 $4.75B $2.45B 1.94
2006-06-30 $4.41B $2.17B 2.03
2006-03-31 $2.87B $2.04B 1.41
2005-12-31 $2.63B $1.48B 1.78
2005-09-30 $2.76B $1.14B 2.42
2005-06-30 $2.72B $1.76B 1.55
2005-03-31 $2.76B $1.78B 1.55
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $49.509B $10.735B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $163.141B 28.29
Medtronic (MDT) Ireland $124.955B 20.30
Stryker (SYK) United States $68.946B 22.38
Baxter (BAX) United States $44.233B 27.00
Lonza Group Ag (LZAGY) Switzerland $39.871B 0.00
Terumo (TRUMY) Japan $29.963B 38.30
EssilorLuxottica Societe Anonyme (ESLOY) France $28.693B 0.00
ResMed (RMD) United States $27.846B 43.95
Zimmer Biomet Holdings (ZBH) United States $24.894B 15.66
Smith & Nephew SNATS (SNN) United Kingdom $17.257B 0.00
Sunny Optical Technology (SNPTF) China $16.924B 0.00
Bio-Rad Laboratories (BIO) United States $13.589B 61.86
Insulet (PODD) United States $12.687B 1256.94
DiaSorin S.p.A (DSRLF) Italy $10.994B 0.00
Quidel (QDEL) United States $9.535B 74.93
Shandong Weigao Medical Polymer (SHWGF) China $8.773B 0.00
Perrigo (PRGO) Ireland $7.523B 13.46
Hill-Rom Holdings (HRC) United States $7.426B 20.93
GN STORE NORD (GNNDY) Denmark $6.972B 0.00
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $5.771B 0.00
Haemonetics (HAE) United States $4.656B 27.96
Neogen (NEOG) United States $4.108B 69.58
GW Pharmaceuticals (GWPH) United Kingdom $3.892B 0.00
ICU Medical (ICUI) United States $3.890B 28.38
Agios Pharmaceuticals (AGIO) United States $3.836B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.805B 0.00
Envista Holdings (NVST) United States $3.407B 0.00
NuVasive (NUVA) United States $2.925B 23.49
National Vision Holdings (EYE) United States $2.458B 42.53
TG Therapeutics (TGTX) United States $2.213B 0.00
AtriCure (ATRC) United States $1.855B 0.00
MacroGenics (MGNX) United States $1.450B 0.00
Aurora Cannabis (ACB) Canada $1.390B 0.00
NanoString Technologies (NSTG) United States $1.322B 0.00
Aphria (APHA) Canada $1.231B 0.00
Cardiovascular Systems (CSII) United States $1.137B 0.00
Cerus (CERS) United States $1.109B 0.00
Phibro Animal Health (PAHC) United States $1.055B 21.02
Meridian Bioscience (VIVO) United States $1.019B 38.37
PetIQ (PETQ) United States $1.017B 29.37
DFB Healthcare Acquisitions (AHCO) United States $0.924B 153.85
InMode (INMD) Israel $0.897B 18.97
Vapotherm (VAPO) United States $0.881B 0.00
Zynex (ZYXI) United States $0.834B 83.73
Omeros (OMER) United States $0.826B 0.00
Quanterix (QTRX) United States $0.789B 0.00
OraSure Technologies (OSUR) United States $0.746B 150.25
Eagle Pharmaceuticals (EGRX) United States $0.663B 47.51
Surmodics (SRDX) United States $0.585B 70.49
VAREX IMAGING (VREX) United States $0.584B 14.50
Lantheus Holdings (LNTH) United States $0.579B 11.65
LeMaitre Vascular (LMAT) United States $0.532B 30.29
BioLife Solutions (BLFS) United States $0.467B 163.45
Owens & Minor (OMI) United States $0.464B 12.27
Repro-Med Systems (KRMD) United States $0.394B 302.33
Viemed Healthcare (VMD) United States $0.367B 32.55
Cytosorbents (CTSO) United States $0.361B 0.00
Utah Medical Products (UTMD) United States $0.315B 22.85
HEXO (HEXO) $0.311B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.304B 0.00
Organigram Holdings (OGI) Canada $0.285B 0.00
Female Health (VERU) United States $0.229B 0.00
Chimerix (CMRX) United States $0.196B 0.00
Bovie Medical (APYX) United States $0.185B 0.00
Evolus (EOLS) United States $0.185B 0.00
Surface Oncology (SURF) United States $0.178B 0.00
Exagen (XGN) United States $0.161B 0.00
Fonar (FONR) United States $0.135B 11.94
Rockwell Medical (RMTI) United States $0.133B 0.00
United Health Products (UEEC) United States $0.131B 0.00
Liberty Health Sciences (LHSIF) Canada $0.120B 0.00
Wound Management Technologies (SMTI) United States $0.112B 0.00
MTech Acquisition (KERN) United States $0.109B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.084B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.082B 0.00
Nephros (NEPH) United States $0.073B 0.00
United-Guardian (UG) United States $0.071B 16.51
Capricor Therapeutics (CAPR) United States $0.065B 0.00
Brainsway (BWAY) Israel $0.065B 0.00
Trinity Biotech (TRIB) Ireland $0.055B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.027B 0.00
NF Energy Saving (BIMI) China $0.022B 0.00
Akers Biosciences Inc (AKER) United States $0.017B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.012B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00